Purchase of Own Securities

GlaxoSmithKline PLC
29 March 2004

GlaxoSmithKline plc (the "Company") announces that in accordance with the
authority granted by shareholders at the Company's Annual General Meeting on 19
May 2003 it purchased 450,000 of its Ordinary shares of 25pence each ("shares")
on 29 March 2004 at a price of 1074.1179 pence per share.

The Company intends to hold these shares in Treasury.

Following the purchase of these shares, the Company holds 8,820,000 of its
shares in Treasury and has 5,925,737,190 shares in issue (excluding Treasury
shares).

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer to purchase or subscribe for securities in any
jurisdiction.


                      This information is provided by RNS
            The company news service from the London Stock Exchange